Efficacy of finasteride 1 mg in the treatment of androgenetic alopecia in men

Experimental Dermatology

Volumn 8, Issue 4, 1999, Pages 302-303

  Olsen, E A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; MINOXIDIL; VIPROSTOL;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; HAIR ANALYSIS; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; ORAL DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALOPECIA; CHOLESTENONE 5 ALPHA-REDUCTASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; OXIDOREDUCTASES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0032788864     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Olsen E A, Delong E, Weiner M S. Reply to "Evaluation techniques for male pattern baldness." J Am Acad Dermatol 1986: 14: 850-951.
2. Rushton D H, Mortimer C, James K C. The unit area trichogram in the assessment of androgen dependent alopecia. Br J Dermatol 1983: 109: 429-437.
3. Olsen E A, Weiner M S, DeLong E R, Pinnell S R. Topical minoxidil in early male pattern baldness. J Am Acad Dermatol 1985: 13: 185-192.
4. Trancik R J, Strauss P C, Albert D G, Kolenc-Saban A, Means L K. Efficacy Comparison of 5% Topical Minoxidil Solution, Rogaine® Topical Solution 2% and Placebo in the Treatment of Male Androgenetic Alopecia. Unpublished data, Pharmacia and Upjohn.
5. Olsen E A, DeLong E R. Transdermal viprostol in the treatment of male pattern baldness. J Am Acad Dermatol 1990: 23: 470-472.
6. Kaufman K D, Olsen E A, Whiting D, Savin R et al. Finasteride 1 Mg/Day in the tTreatment of Men with Androgenetic Alopecia (Male Pattern Hair Loss). Submitted to J Am Acad Dermatol.